Mayo Clinic Launches Joint Ventures to Create and Market AI Diagnostic Tools


James R. Martin / Shutterstock

Mayo Clinic announced wednesday that he has launched two new technology companies designed to harness artificial intelligence (AI) and medical algorithms to create “software as medical devices” that clinicians can use to improve the treatment of different diseases.

The two new companies – Anumana Inc. and Lucem Health Inc. – were launched with a $ 30 million investment from the Mayo Clinic and its venture capital partners.

Anumana completed a $ 25.7 million Series A funding round, led by founding organizations nference and Mayo Clinic and in collaboration with Matrix Capital Management, Matrix Partners and NTVC.

Lucem Health closed a $ 6 million Series A funding round ahead of its launch, led by founders Commure and Mayo Clinic.

In a statement from the Mayo Clinic, the two new tech companies will focus on providing next-generation clinical decision support tools, diagnostic information and care recommendations. Both companies’ AI and medical algorithms will use Mayo Clinic’s medical knowledge, gathered from the organization’s patient records, to develop digital tools that will provide better treatment options for patients with various illnesses.

The companies will leverage Mayo Clinic’s Remote Diagnosis and Management (RDMP) platform, which connects data to innovative new AI algorithms and works to influence clinician decision-making to improve care .

“The dramatically increased use of remote patient telemetry devices, coupled with the rapid acceleration in the development of AI and machine learning algorithms, has the potential to revolutionize diagnostic medicine,” said John Halamka, MD, chair of the Mayo Clinic platform. “With RDMP, clinicians will have access to the best algorithms and care protocols and will be able to serve more patients effectively in remote care environments. The platform will also allow patients to have better control over their health and make better decisions based on the information provided directly to them. “

Anumana will work on the development and commercialization of new digital sensor diagnostic tools using a combination of nference AI and the Mayo Clinic medical data repository. Initially, the new company will focus on developing cutting-edge neural network algorithms, incorporating billions of heart health data from Mayo Clinic’s clinical data analysis platform. This work aims to uncover new biomedical knowledge regarding cardiovascular problems, thus facilitating early detection and better treatments for heart disease.

“For many conditions, such as a weak or thickened heart pump, or silent arrhythmias, there are effective, evidence-based treatments that can prevent heart failure, stroke or death,” Paul said. Friedman, MD, chairman of the Mayo Clinic Department of Cardiovascular Medicine. “The key is to detect the disease before symptoms develop to prevent these events from occurring. The addition of AI to the ECG, a ubiquitous and inexpensive point-of-care test that is already integrated in medical workflows, makes this approach good for patients, convenient for clinicians and extremely scalable. “

The co-founder and CEO of nference and CEO of Anumana, Murali Aravamudan, added, “Our augmented intelligence technology, in the hands of scientific and clinical experts, will enable a complete translation of the language of the heart. We regard it as the Rosetta Stone for cardiac medicine. “

Lucem Health was launched by the Commure and Mayo Clinic to provide the platform that will connect remote patient telemetry devices with algorithms enhanced by AI technology. Ultimately, the company plans to integrate all of the diagnostic information generated from these algorithms into real-world clinical workflows.

“Lucem Health exists to help innovations in diagnostic medicine come to life,” said Sean Cassidy, founding CEO of Lucem Health. “We are excited to be working with partners like the Mayo Clinic and Anumana who are reinventing the way we detect and treat disease. “

Source link

Leave A Reply

Your email address will not be published.